Cargando…
Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer
Vasohibin‐1 (VASH1) is a VEGF‐inducible endothelium‐derived angiogenesis inhibitor, and vasohibin‐2 (VASH2), its homolog, exhibits proangiogenic activity. VASH2 is expressed by various cancer cells and accelerates tumor angiogenesis and progression. VASH2 was recently shown to exhibit tubulin carbox...
Autores principales: | Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026928/ https://www.ncbi.nlm.nih.gov/pubmed/33710778 http://dx.doi.org/10.1002/cam4.3841 |
Ejemplares similares
-
Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report
por: Umihira, Shuntaro, et al.
Publicado: (2022) -
Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016) -
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
por: TAKAHASHI, YOSHIFUMI, et al.
Publicado: (2015) -
Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trial
por: Fujiwara, Hiroyuki, et al.
Publicado: (2015) -
Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)